Диссертация (1141152), страница 19
Текст из файла (страница 19)
–2006. – Vol. 114. – P. 921-928.139. Suttorp, M.J. Prison III study investigators. A randomized comparison ofsirolimus – eluting stent implantation with zotarolimus – eluting stentimplantation for the treatment of total coronary occlusions: rationale anddesign of the PRImary Stenting of Occluded Native coronary arteries III(Prison III) study / M.J. Suttorp, G.J. Laarman // Amer. Heart J.
– 2007. – Vol.154, № 3. – P. 432-435.140. The Criteria Committee of the New York Heart Association.Nomenclature and Criteria for Diagnosis of Diseases of the Heart and GreatVessels. – 9th ed. – Boston, MA : Little, Brown & Co, 1994. – P. 253-256.124141. The new manual of interventional Cardiology / Ed. by M. Freed, R.Safian, C. Grines. – Birmingham, Michigan: Physician press, 1994. – 481 р.142. The role of apoptosis in the initiation of vascular calcification / D.Proudfoot, J.N.
Skepper, L. Hegyi [et al.] // Z. Kardiol. – 2001. – Vol. 90,Suppl. 3. – P. 43-46.143. Thompson, Craig A. US CTO PCI 2011 How do we catch up with theJapanese and Europeans / Craig A. Thompson // Presentation at the 26th annualInterventional Cardiology Symposium (USA, Colorado, Snowmass, 13-18 mar.2011).144. Three-year Angiographic Follow-up of Coronary Stenting in PatientsWith Chronic Total Occlusion / K. Yamasaki, T. Nakamura, H. Yung-Sheng[et al.] // Am J Cardiol. – 1998.
– Vol. 71. – P. 932-942.145. Thrombolysis in Myocardial Infarction (TIMI) Trial, phase I: acomparison between intravenous tissue plasminogen activator and intravenousstreptokinase: clinical findings through hospital discharge / J.H. Chesebro, G.Knatterud, R. Roberts [et al.] // Circulation. – 1987. – Vol.
76. – P. 142-154.146. Transforming growth factor type beta induces monocyte chemotaxis andgrowth factor production / S.M. Wahl, D.A. Hunt, L.M. Wakefield [et al.] //Proc. Natl. Acad. Sci. USA. – 1987. – Vol. 84. – P. 5788-5792.147. Treatment of chronic total occlusion with the sirolimus – eluting stents:12 month results from the e – Cypher Registry / C. Lotan, A.H. Gershlick, G.Guagliumi [et al.] // Presented at ACC Scientific Sesion. – Orlando, 2005.148. Trends in outcomes after percutaneous coronary intervention for chronictotal occlusions: a 25-year experience from the Mayo Clinic / A. Prasad, C.S.Rihal, R.J.
Lennon [et al.] // J. Am. Coll. Cardiol. – 2007. – Vol. 49, № 15. – P.1611-1618.149. Tsuchikane, E. Advanced techniques for antegrade advancement of wires/ E. Tsuchikane // Handbook of Chronic Total Occlusions. Chapter 3 / Ed. byG. Dangas, R. Mehran, J. Moses. – Informa Healthcare, 2010. – P. 21-29.125150. Tsuchikane, E. Long-Term Angiographic Patency of RecanalizedChronic Coronary Total Occlusions Associated with Sub-Intimal Dilatation / E.Tsuchikane, T. Kobayashi, N.
Awata // Lancet. – 1999. – Vol. 435. – P. 10011012.151. Vaina, S. Treatment of multi-vessel coronary artery disease: What is theoptimal revascularization approach? What do we know, what will we learn? /S. Vaina, C. Stefanadis // Hellenic. J.
Cardiol. – 2007. – Vol. 48. – P. 1-4.152. Vessel reconstruction in total coronary occlusions with a long subintimalwire pathway: use of multiple stents under guidance of intravascular ultrasound/ G.S. Werner, J. Diedrich, K.H. Scholz [et al.] // Cathet. Cardiovasc.
Diagn. –1997. – Vol. 40, № 1. – P. 46-51.153. Weisz, G. Contemporary Principles of Coronary chronic Total OcclusionRecanalization / G. Weisz, J. W. Moses // Catheterization and cardiovascularinterventions. – 2010. – Vol. 75. – P. 21-27.154. Werner, Gerald S. Tools and Techniques: The antegrade recanalizationtechnique for CTO / Gerald S. Werner // EuroIntervention. – 2011. – Vol. 6, №9. – P.
1137-1139.155. Wu, E.B. Retrograde chronic total occlusion intervention: tips and tricks /E.B. Wu, W.W. Chan, C.M. Yu // Catheter. Cardiovasc. Interv. – 2008. – Vol.72. – P. 806-814.156. Yee, K.O. Why atherosclerotic vessels narrow: The fibrin hypothesis /K.O. Yee, S.M.
Schwartz // Thromb Haemost. – 1999. – Vol. 82, № 2. – P.762-771.157. Yoshida, K. Quantitative relation of myocardial infarct size andmyocardial viability by positron emission tomography to left ventricularejection fraction and 3-year mortality with and without revascularization / K.Yoshida, K.L. Gould // J. Am. Coll. Cardiol.
– 1993. – Vol. 22. – P. 984-997..